Rift Valley Fever

11 registered clinical trials studyying Rift Valley Fever — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910	Institut Pasteur du Cambodge	—
Active Not Recruiting	Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003) NCT06799234	University of Oxford	Phase 2
Active Not Recruiting	Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011 NCT06925919	IDBiologics, Inc.	Phase 1
Completed	A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults NCT04672824	University of Oxford	Phase 1
Unknown	RVF and Other Emerging Infectious Diseases in East and Central Africa NCT05139524	Washington State University	—
Completed	Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001) NCT04754776	University of Oxford	EARLY_Phase 1
Recruiting	Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine NCT03609398	U.S. Army Medical Research and Development Command	Phase 2
Completed	Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated NCT00869713	U.S. Army Medical Research and Development Command	Phase 2
Completed	Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine NCT00415051	U.S. Army Medical Research and Development Command	Phase 2
Completed	Rift Valley Fever in Kenya NCT00287014	National Institute of Allergy and Infectious Diseases (NIAID)	—
Completed	Safety and Immunogenicity Study of Rift Valley Fever Vaccine NCT00584194	U.S. Army Medical Research and Development Command	Phase 2